drug · small molecule
glatiramer acetate ER
Phase 2updated 5mo agoby Mapi Pharma Ltd🔗 ChEMBL
Phase 2community read0 votes
🐶 often sniffed alongside
top 4Small molecule drug with a maximum clinical stage of Approval (across all indications), with an approval for multiple sclerosis and neoplasm and 8 investigational indications.
all catalysts(0)
nothing on the calendar yet
Trials studying glatiramer acetate ER
- —A NIS Evaluating Various Injectable and Oral Treatments in Patients With Relapsing Multiple Sclerosis
- —A Study to Learn More About The Safety of Diroximel Fumarate (VUMERITY®) in Participants Who Took it During Pregnancy And About the Health of Their Babies
- phase3A Study to Evaluate Efficacy, Safety, and Tolerability of Alemtuzumab in Pediatric Patients With RRMS With Disease Activity on Prior DMT
- phase4A Open-label Study to Assess Response to COVID-19 Vaccine in Multiple Sclerosis Participants Treated With Ofatumumab
- —Copaxone Subcutaneous Injection Syringe Special Drug Use-Result Investigation (All-Case Investigation) "Prevention of Relapse of Multiple Sclerosis"
- phase2Study to Evaluate Oral BIIB061 Added to Interferon-beta1 (IFN-β1) or Glatiramer Acetate in Relapsing Multiple Sclerosis (RMS)
News(1)
- STAT+: Turkish antitrust authorities probe Teva for allegedly gaming the patent system, disparaging rival drugsTurkish regulators are investigating Teva Pharmaceutical for allegedly manipulating the patent system and disparaging rival drugs.stat · 1mo ago
Data sources
last refreshed 2h ago
Found something off?
comments(0)
5-min edit window · permanent after that